Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 6
Doktorska disertacija
Oznake: encimi;papainu podobne peptidaze;alosterija;hiperbolični inhibitor;sinteza;molekulsko sidranje;encimska kinetika;doktorske disertacije;
Človeška katepsina K in S sta člana družine papainu podobnih peptidaz z zelo podobnima terciarnima strukturama. V človeškem telesu imata številne fiziološke vloge, pri čemer je najpomembnejša biološka vloga katepsina K razgradnja kolagenskih vlaken kostnega tkiva, medtem ko ima katepsin S zelo ...
Leto: 2022 Vir: Fakulteta za kemijo in kemijsko tehnologijo (UL FKKT)
Izvirni znanstveni članek
Oznake: molecular design;molecular simulations;deep learning;human DNA;topoisomerase IIα;catalytic inhibitors;anticancer agents;
The 4,6-substituted-1,3,5-triazin-2(1H)-ones are promising inhibitors of human DNA topoisomerase IIα. To further develop this chemical class targeting the enzyme´s ATP binding site, the triazin-2(1H)-one substitution position 6 was optimized. Inspired by binding of preclinical substituted 9H-purine ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake: protein 90 (Hsp90);inhibition of protein–protein interaction;virtual screening;ligand-based pharmacophore models;
The interaction between heat shock protein 90 (Hsp90) and Hsp90 co-chaperone cell-division cycle 37 (Cdc37) is crucial for the folding and maturation of several oncogenic proteins, particularly protein kinases. This makes the inhibition of this protein–protein interaction (PPI) an interesting target ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake: cancer;Ewing sarcoma;Hsp90;inhibitor;topoisomerase IIα;zebrafish;
Heat shock protein 90 (Hsp90) and topoisomerase IIα (TopoIIα) are members of the GHKL protein superfamily, both with clinically validated roles as anticancer drug targets. We report the discovery of the first class of dual inhibitors targeting the ATP-binding site of TopoIIα and the C-terminal domai ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake: cancer;Hsp90;isoform selectivity;topoisomerase II;
Due to their impact on several oncogenic client proteins, the Hsp90 family of chaperones has been widely studied for the development of potential anticancer agents. Although several Hsp90 inhibitors have entered clinical trials, most were unsuccessful because they induced a heat shock response (HSR) ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Izvirni znanstveni članek
Oznake: cancer;Hsp90;inhibitor;Ewing sarcoma;zebrafish;
The development of new anticancer agents is one of the most urgent topics in drug discovery. Inhibition of molecular chaperone Hsp90 stands out as an approach that affects various oncogenic proteins in different types of cancer. These proteins rely on Hsp90 to obtain their functional structure, and ...
Leto: 2024 Vir: Fakulteta za farmacijo (UL FFA)
Št. zadetkov: 6
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: